Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for acute acquired superior oblique muscle palsy
ChiCTR2400094561Phase 4Recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A in superior oblique palsy (SOP) (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Cure rate. Started Jan 2025; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
superior oblique palsy (SOP)
Beyond the preview
Go deeper on ChiCTR2400094561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094561.